Uninterrupted Use of Oral Anticoagulants for the Ablation of Atrial Flutter: A Single Center Cohort of 154 Patients | Zendy

Tiago Luiz Luz Leiria | Zendy; Alexandre Kreling Medeiros | Zendy; Eduardo Dytz Almeida | Zendy; Antonio Lessa Gaudie Ley | Zendy; Catarine Benta Lopes dos Santos | Zendy; Roberto Toffani Sant'Anna | Zendy; Marcelo Lapa Kruse | Zendy; Leonardo Martins Pires | Zendy; Gustavo Glotz de Lima | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Uninterrupted Use of Oral Anticoagulants for the Ablation of Atrial Flutter: A Single Center Cohort of 154 Patients

Author(s) -

Tiago Luiz Luz Leiria,

Alexandre Kreling Medeiros,

Eduardo Dytz Almeida,

Antonio Lessa Gaudie Ley,

Catarine Benta Lopes dos Santos,

Roberto Toffani Sant'Anna,

Marcelo Lapa Kruse,

Leonardo Martins Pires,

Gustavo Glotz de Lima

Publication year - 2017

Publication title -

arquivos brasileiros de cardiologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.4

H-Index - 53

eISSN - 1678-4170

pISSN - 0066-782X

DOI - 10.5935/abc.20180001

Subject(s) - medicine , atrial flutter , single center , ablation , atrial fibrillation , cohort , cardiology , center (category theory) , flutter , engineering , chemistry , aerodynamics , crystallography , aerospace engineering

The uninterrupted use of oral anticoagulation (OAC) with vitamin K antagonists (VKAs) for electrophysiology procedures has been more and more recommended. The clinical practice in our service recommends the continuous use of these drugs for atrial flutter ablation. There is little evidence as to the uninterrupted use of non-vitamin K antagonist oral anticoagulants (NOACs) in this scenario.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research